[1]吴晓明,韩　华,吴煌福.乳腺浸润性导管癌组织中肽基脯氨酰顺反异构酶1和细胞周期蛋白D1的表达及临床意义[J].新乡医学院学报,2018,35(12):1118-1121.[doi:10.7683/xxyxyxb.2018.12.019]
　WU Xiao-ming,HAN Hua,WU Huang-fu.Clinical significance of the expression of peptidyl-prolyl cis-trans-isomerase 1 and Cyclin D1 in invasive ductal carcinoma of breast[J].Journal of Xinxiang Medical University,2018,35(12):1118-1121.[doi:10.7683/xxyxyxb.2018.12.019]
点击复制

乳腺浸润性导管癌组织中肽基脯氨酰顺反异构酶1和细胞周期蛋白D1的表达及临床意义
分享到：

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
35
期数:
2018年12
页码:
1118-1121
栏目:
临床研究
出版日期:
2018-12-05

文章信息/Info

Title:
Clinical significance of the expression of peptidyl-prolyl cis-trans-isomerase 1 and Cyclin D1 in invasive ductal carcinoma of breast
作者:
吴晓明; 韩　华; 吴煌福
（海南医学院第二附属医院肿瘤外科，海南　海口　570311）
Author(s):
WU Xiao-ming; HAN Hua; WU Huang-fu
（Department of Oncological Surgery，the Second Affiliated Hospital of Hainan Medical University，Haikou 570311，Hainan Province，China）
关键词:
乳腺浸润性导管癌; 肽基脯氨酰顺反异构酶1; 细胞周期蛋白D1
Keywords:
invasive ductal carcinoma of breast; peptidyl-prolyl cis-trans-isomerase 1; Cyclin D1
分类号:
R737.9
DOI:
10.7683/xxyxyxb.2018.12.019
文献标志码:
A
摘要:
目的　探讨肽基脯氨酰顺反异构酶1（Pin1）和细胞周期蛋白D1（Cyclin D1）在乳腺浸润性导管癌组织中的表达，分析Pin1和Cyclin D1表达与乳腺癌临床特征的相关性。方法　选取2013年1月至2015年1月海南医学院第二附属医院保存的80例乳腺浸润性导管癌组织和40例癌旁正常乳腺组织标本，采用免疫组织化学法检测乳腺浸润性导管癌组织和正常乳腺组织中Pin1和Cyclin D1的表达，并分析Pin1和Cyclin D1表达与乳腺浸润性导管癌病理分级、TNM分期及淋巴结转移的相关性。结果　乳腺浸润性导管癌组织中Pin1和Cyclin D1阳性表达率分别为56.3%（45/80）、45.0%（36/80），正常乳腺组织中Pin1和Cyclin D1阳性表达率分别为12.5%（5/40）、20.0%（8/40）；乳腺浸润性导管癌组织中Pin1和Cyclin D1阳性表达率显著高于正常乳腺组织（χ2=21.001、7.170，P<0.05）。Pin1表达与乳腺浸润性导管癌病理学分级及淋巴结转移有关（χ2=10.381、4.085，P<0.05），与TNM分期无关（χ2=2.544，P>0.05）。Cyclin D1表达与乳腺浸润性导管癌病理学分级有关（χ2=7.024，P<0.05），与TNM分期及淋巴结转移无关（χ2=3.236、0.191，P>0.05）。乳腺浸润性导管癌组织中Pin1与CyclinD1表达呈正相关（χ2=4.363，P<0.05）。结论　Pin1和Cyclin D1在乳腺浸润性导管癌组织中表达上调，其可能与乳腺浸润性导管癌的发生、发展有关。
Abstract:
Objective　To investigate the expression of peptidyl-prolyl cis-trans isomerase 1 （Pin1） and Cyclin D1 in invasive ductal carcinoma of breast，and to analyze the correlation between the expression of Pin1 and Cyclin D1 and the clinical characteristics of breast cancer.Methods　Eighty cases of invasive ductal breast cancer and forty cases of normal breast tissue specimens in the Second Affiliated Hospital of Hainan Medical University from January 2013 to January 2015 were selected.The expression of Pin1 and Cyclin D1 in invasive ductal carcinoma and normal breast tissues were detected by immunohistochemistry.The correlation between Pin1 and Cyclin D1 expression and pathological grading，TNM stage and lymph node metastasis of invasive ductal carcinoma was analyzed.Results　The positive expression rates of Pin1 and Cyclin D1 in breast invasive ductal carcinoma were 56.3% （45/80） and 45.0% （36/80），respectively；the positive expression rates of Pin1 and Cyclin D1 in normal breast tissues were 12.5% （5/40） and 20.0% （8/40），respectively；the positive expression rates of Pin1 and Cyclin D1 in breast invasive ductal carcinoma tissues were significantly higher than those in normal breast tissues （χ2=21.001，7.170；P<0.05）.The expression of Pin1 was correlated with pathological grading and lymph node metastasis of breast invasive ductal carcinoma （χ2=10.381，4.085；P<0.05），but it was not related to TNM stage （χ2=2.544，P>0.05）.The expression of Cyclin D1 was correlated with pathological grading of invasive ductal carcinoma （χ2=7.024，P<0.05），but it was not related to TNM staging and lymph node metastasis （χ2=3.236，0.191；P>0.05）.The expression of Pin1 was positively correlated with CyclinD1 expression in invasive ductal carcinoma （χ2=4.363，P<0.05）.Conclusion　The expressions of Pin1 and Cyclin D1 are up-regulated in invasive ductal carcinoma of breast，it may be related to the occurrence and development of invasive ductal carcinoma of breast.

参考文献/References:

［1］　孙慧，张静，战忠利，等.雌激素及雌激素受体拮抗剂对乳腺癌信号传导通路中MEK-2和p-ERK病理形态的影响［J］.中国肿瘤临床，2008，35（4）：219-223.
［2］　XU M，CHEUNG C C，CHOW C，et al.Overexpression of PIN1 enhances cancer growth and aggressiveness with Cyclin D1 induction in EBV-associated nasopharyngeal carcinoma［J］.PLoS One，2016，11（6）：e0156833.
［3］　PESTELL R G，SANTE G D，ROCCO A D，et al.Cyclin D1 binding to chromatin and the induction of chromosomal instability requires the fuzzy domain［J］.Cancer Res，2017，77（Suppl 4）：5-9.
［4］　SHI K，LIU X，LI H，et al.Menin modulates mammary epithelial cell numbers in bovine mammary glands through Cyclin D1［J］.J Mammary Gland Biol Neoplasia，2017，22（4）：221-233.
［5］　KUO Y H，CHIANG E I，CHAO C Y，et al.Dual inhibition of key proliferation signaling pathways in triple negative breast cancer cells by a novel derivative of Taiwanin A［J］.Mol Cancer Ther，2017，16（3）：480-493.
［6］　李红雨.宫颈癌中Pin1过表达对Cyclin D1调节及其在宫颈癌细胞增殖凋亡的作用机制研究［D］.武汉：华中科技大学，2006.
［7］　SONG L，LI L，LIU B，et al.Diagnostic evaluations of ultrasound and magnetic resonance imaging in mammary duct ectasia and breast cancer［J］.Oncol Lett，2018，15（2）：1698-1706.
［8］　NGUYEN F，PEA L，IBISCH C，et al.Canine invasive mammary carcinomas as models of human breast cancer.Part 1：natural history and prognostic factors［J］.Breast Cancer Res Treat，2018，167（3）：635-648.
［9］　钟鸣，刘英霞，翁剑华，等.乳腺浸润性导管癌组织中Pin1、CyclinD1蛋白表达变化及意义［J］.山东医药，2017，57（9）：55-57.
［10］　SCHNEIDER S，THURNHER D，SEEMANN R，et al.The prognostic significance of β-catenin，Cyclin D1 and Pin1 in minor salivary gland carcinoma：β-catenin predicts overall survival［J］.Eur Arch Otorhinolaryngol，2015，273（5）：1283-1292.
［11］　疏楠，李连宏，孙志刚，等.P16、CDK4、CyclinD1在乳腺癌中的表达及临床意义［J］.大连医科大学学报，2009，31（4）：255-259.
［12］　杨发林.雷洛昔芬的心血管作用及相关分子生物学机制研究［D］.济南：山东大学，2007.
［13］　PESTELL T G，JIAO X，KUMAR M，et al.Stromal Cyclin D1 promotes heterotypic immune signaling and breast cancer growth［J］.Oncotarget，2017，8（47）：81754-81775.
［14］　韩小敏.以PLK1和Pin1为靶点的新型抗肿瘤药物的筛选及分子药理学研究［D］.北京：北京协和医学院，2012.
［15］　KIM J H，JUNG J H，KIM S H，et al.Decursin exerts anti-cancer activity in MDA-MB-231 breast cancer cells via inhibition of the Pin1 activity and enhancement of the Pin1/p53 association［J］.Phytother Res，2014，28（2）：238-244.
［16］　NICOLE TSANG Y N，WU X W，LIM J S，et al.Prolyl isomerase Pin1 downregulates tumor suppressor RUNX3 in breast cancer［J］.Oncogene，2013，32（12）：1488-1496.
［17］　RYO A，UEMURA H，ISHIGURO H，et al.Stable suppression of tumorigenicity by Pin1-targeted RNA interference in prostate cancer［J］.Clin Cancer Res，2005，11（20）：7523-7531.
［18］　HE J，ZHOU F，SHAO K，et al.Overexpression of Pin1 in non-small cell lung cancer （NSCLC） and its correlation with lymph node metastases［J］.Lung Cancer，2007，56（1）：51-58.

相似文献/References:

[1]陈志军,卢建国,姚文健,等.肽基脯氨酰顺反异构酶1 和细胞周期蛋白D1 在食管鳞状细胞癌中的表达[J].新乡医学院学报,2012,29(07):505.

更新日期/Last Update: 2018-12-05